2015
CPT1a mutation leads the way for new medication for the treatment of multiple sclerosis.
Multiple Sclerosis Journal, 21 (11 Suppl.), 786-787, No. P1497.
Nieland, J. D., Nieland, J. G. K., Mørkholt, A. S., Bolther, L., Corthals, A., Issazadeh-Navikas, A, Luise Bolther & Nielsen, S.
DOI: 10.1177/1352458515604791